Sutro Biopharma, Inc. Financial Ratios — STRO Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-48.62	-14.95	-36.11	-50.77	-58.25	-234.19	- -
Return on Assets (%)	- -	-35.78	-26.76	-29.38	-11.67	-28.7	-31.86	-24.34	-53.02	-68.12
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	11.76	-27.6	-85.07	-118.61	-156.27	-151.39	-181.86	-53.64	-372.7	-95.26
Operating Margin (%)	2.28	-37.25	-96.89	-129.79	-166.32	-159.22	-190.26	-58.07	-384.34	-102.41
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	2.85	-38.05	-91.93	-130.44	-74.96	-170.55	-172.2	-57.63	-362.81	-186.55
Profit Margin (%)	2.85	-38.05	-91.93	-130.44	-75.2	-170.55	-175.89	-69.47	-366.62	-186.45
Net Income to Common Margin (%)	- -	-38.05	-91.93	-130.44	-75.2	-170.55	-175.89	-69.47	-366.62	-186.45
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-48.62	-14.95	-36.11	-50.77	-58.25	-234.19	- -

Credit (USD)

Credit Ratios API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	15	15	10	25	57	50	34	23	16
ST Debt	- -	15	5	1	- -	10	17	10	7	8
LT Debt	- -	- -	10	9	25	47	33	23	16	8
Total Debt/EBITDA	- -	-1.02	-0.45	-0.19	-0.37	-0.61	-0.41	-0.41	-0.1	-0.16
Net Debt/EBITDA	-1.65	0.52	3.38	-0.1	2.72	0.06	0.25	0.79	0.82	0.6
Total Debt/EBIT	- -	-0.76	-0.4	-0.18	-0.35	-0.58	-0.39	-0.38	-0.1	-0.15
Net Debt/EBIT	-8.5	0.39	2.97	-0.09	2.56	0.05	0.24	0.73	0.8	0.55
EBITDA to Interest Expense	- -	-20.73	-20.14	-11.65	-16.8	-29.86	-36.84	-3.47	-7.44	-2.32
EBITDA-CapEx/Interest Expense	- -	-25.54	-21.1	-12.45	-18.59	-34.75	-39.18	-3.65	-7.54	-2.36
EBIT to Interest Expense	- -	-27.97	-22.93	-12.75	-17.88	-31.41	-38.54	-3.76	-7.67	-2.5
Interest Expense	- -	1	2	4	4	3	3	24	31	42
Common Equity/Total Assets	-131.21	-267.36	58.95	62.54	84.25	73.98	53.34	31.79	11.52	-76.2
Long-Term Debt/Equity (%)	- -	- -	7.6	9.08	7.39	18.59	15.36	15.47	35.14	- -
Long-Term Debt/Capital (%)	- -	- -	6.84	8.24	6.88	15.15	12.47	12.63	23.13	-6.76
Long-Term Debt/Total Assets (%)	- -	- -	4.48	5.68	6.23	13.76	8.19	4.92	4.05	4.54
Total Debt/Equity (%)	- -	-13.36	11.19	10.1	7.39	22.72	23.23	22.48	51.91	-11.83
Total Debt/Capital (%)	- -	-15.42	10.07	9.17	6.88	18.51	18.85	18.35	34.17	-13.42
Total Debt/Total Assets (%)	- -	35.72	6.6	6.32	6.23	16.81	12.39	7.15	5.98	9.02
Net Debt to Equity	12.75	6.84	-84.06	5.03	-54.69	-2.1	-14.27	-43.57	-426.68	43.89
Net Debt/Capital (%)	11.31	6.4	-527.42	4.79	-120.72	-1.9	-14.07	-57.19	155.29	33.23
EBITDA	7	-14	-33	-51	-67	-94	-123	-82	-231	-98
EBITDA-CapEx	3	-18	-34	-54	-74	-109	-131	-87	-234	-99
Operating Income (Loss)	1	-19	-37	-55	-71	-99	-129	-89	-238	-105

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.95	0.69	5.61	3.58	12.44	4.74	5.02	4.01	2.4	1.88
Current Ratio	0.99	0.8	5.76	3.9	12.78	5.24	5.31	4.5	2.6	2.01
Quick Ratio	0.96	0.74	5.68	3.77	12.63	5.04	5.13	4.39	2.47	1.94
CFO/Avg Current Liab	- -	-0.9	0.37	-1.87	-2.17	-2.29	0.07	-1.39	-1.7	-1.71
Common Equity/Total Assets	-131.21	-267.36	58.95	62.54	84.25	73.98	53.34	31.79	11.52	-76.2
Long-Term Debt/Equity (%)	- -	- -	7.6	9.08	7.39	18.59	15.36	15.47	35.14	- -
Long-Term Debt/Capital (%)	- -	- -	6.84	8.24	6.88	15.15	12.47	12.63	23.13	-6.76
Long-Term Debt/Total Assets (%)	- -	- -	4.48	5.68	6.23	13.76	8.19	4.92	4.05	4.54
Total Debt/Equity (%)	- -	-13.36	11.19	10.1	7.39	22.72	23.23	22.48	51.91	-11.83
Total Debt/Capital (%)	- -	-15.42	10.07	9.17	6.88	18.51	18.85	18.35	34.17	-13.42
Total Debt/Total Assets (%)	- -	35.72	6.6	6.32	6.23	16.81	12.39	7.15	5.98	9.02
CFO/Total Liabilities	-8.21	-24.75	13.85	-111	-109.25	-91.94	1.87	-34.76	-55.91	-57.87
CFO/CapEx	-2.99	-11.18	8.15	-18.68	-9.51	-5.33	0.45	-25.87	-61.83	-104.56
Altman's Z-Score	-1.01	-4.43	0.96	0.69	9.37	3.14	-0.12	-0.64	-3.8	-8.56

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	47.02	18.68	9.73	7.21	6.87	6.92	7.12	2.78	16.28
Days Sales Outstanding	- -	7.76	19.54	37.52	50.65	53.12	52.72	51.28	131.47	22.43
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	206	254	993	689	465	262	152	99
- Cash & Cash Equivalents	12	22	125	5	206	30	47	69	190	58
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	15	15	10	25	57	50	34	23	16
Enterprise Value	-48	-7	16	146	650	549	181	-80	-142	-26
Total Capital	-91	-94	146	108	357	310	267	183	68	-117
Total Debt/Capital (%)	- -	-15.42	10.07	9.17	6.88	18.51	18.85	18.35	34.17	-13.42
Total Debt / EV	- -	-1.95	0.9	0.07	0.04	0.1	0.28	-0.42	-0.16	-0.59
EV/Sales	- -	- -	0.42	3.42	15.21	8.87	2.67	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	1.14	- -	- -	- -	25.93	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	1.03	- -	- -	- -	12.19	- -	- -	- -
Diluted Market Cap	- -	- -	52	253	707	686	410	258	142	98
Diluted Enterprise Value	-12	-7	-59	257	526	713	413	222	-25	56
EV per Share	- -	- -	7.14	63.25	142	118.46	31.42	- -	- -	- -
TTM Sales	60	52	38	43	43	62	68	154	62	102
TTM EBITDA	7	-14	-33	-51	-67	-94	-123	-82	-231	-98
TTM Operating Income	1	-19	-37	-55	-71	-99	-129	-89	-238	-105
TTM Cash Flow to Firm	-13	-36	14	-61	-64	-79	7	-83	-160	-135
TTM Free Cash Flow to Firm	-9	-33	16	-57	-57	-63	15	-79	-157	-133

Multiples (USD)

Valuation Multiples API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	3.65	-4.1	-11.66	-10.34	35.94	-2.41	-0.76	-0.56
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	-48	-7	16	146	650	549	181	-80	-142	-26
Low Price	- -	- -	85	76.9	60	140.3	33.3	20.05	17	5.23
EV/Sales	- -	- -	0.42	3.42	15.21	8.87	2.67	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-1.98	-4.31	-11.7	-8.75	-2.97	-2.65	-1.3	-0.46
Price/Earnings High	- -	- -	-2.59	-5.14	-25.84	-12.37	-6.67	-4.91	-2.09	-0.96
Price/Earnings Low	- -	- -	-1.39	-3.17	-6.08	-6.13	-1.42	-1.13	-0.58	-0.23
Price/Book Value	- -	- -	1.57	2.6	2.99	2.73	2.14	1.75	3.4	-0.75
Price/Book Value Average	- -	- -	2.11	2.47	1.59	3.67	1.85	1.92	7.08	-0.68
Price/Book Value High	- -	- -	2.76	2.95	3.51	5.19	4.15	3.56	11.34	-1.39
Price/Book Value Low	- -	- -	1.48	1.82	0.83	2.57	0.88	0.82	3.15	-0.34
Price/Tangible Book Value	- -	- -	1.57	2.6	2.99	2.73	2.14	1.75	3.4	-0.75
Price/Tangible Book Value Average	- -	- -	2.11	2.47	1.59	3.67	1.85	1.92	7.08	-0.68
Price/Tangible Book Value High	- -	- -	2.76	2.95	3.51	5.19	4.15	3.56	11.34	-1.39
Price/Tangible Book Value Low	- -	- -	1.48	1.82	0.83	2.57	0.88	0.82	3.15	-0.34
Price/Sales	- -	- -	1.35	5.91	16.55	11.09	6.05	1.68	2.29	0.96
Price/Sales Average	- -	- -	1.82	5.62	8.8	14.92	5.23	1.84	4.77	0.86
Price/Sales High	- -	- -	2.38	6.71	19.43	21.09	11.73	3.41	7.64	1.78
Price/Sales Low	- -	- -	1.27	4.13	4.57	10.46	2.49	0.78	2.12	0.43
Price/Cash Flow	- -	- -	4.1	-3.88	-10.43	-8.4	115.52	-2.31	-0.74	-0.55
Price/Cash Flow Average	- -	- -	5.52	-3.69	-5.55	-11.3	99.84	-2.54	-1.55	-0.5
Price/Cash Flow High	- -	- -	7.22	-4.41	-12.25	-15.98	224.03	-4.7	-2.48	-1.03
Price/Cash Flow Low	- -	- -	3.86	-2.72	-2.88	-7.92	47.61	-1.08	-0.69	-0.25
Price/Free Cash Flow Average	- -	- -	4.92	-3.9	-6.2	-13.91	31.06	-2.64	-1.57	-0.5
Price/Free Cash Flow High	- -	- -	6.43	-4.66	-13.68	-19.67	69.7	-4.89	-2.52	-1.04
Price/Free Cash Flow Low	- -	- -	3.44	-2.87	-3.22	-9.75	14.81	-1.12	-0.7	-0.25
EV/Sales Average	- -	- -	4.35	5.77	8.11	15.42	5.97	1.64	2.4	0.46
EV/Sales High	- -	- -	6.58	6.87	23.05	21.62	13.34	3.23	5.46	1.39
EV/Sales Low	- -	- -	2.18	4.27	2.17	10.94	2.87	0.56	- -	0.02
EV/EBITDA Average	-1.65	0.52	-5.12	-4.86	-5.19	-10.19	-3.28	-3.05	-0.64	-0.48
EV/EBITDA High	-1.65	0.52	-7.73	-5.79	-14.75	-14.28	-7.34	-6.02	-1.46	-1.46
EV/EBITDA Low	-1.65	0.52	-2.56	-3.6	-1.39	-7.23	-1.58	-1.05	0.12	-0.02
EV/EBIT Average	-8.5	0.39	-4.49	-4.44	-4.88	-9.69	-3.14	-2.82	-0.62	-0.45
EV/EBIT High	-8.5	0.39	-6.79	-5.29	-13.86	-13.58	-7.01	-5.56	-1.42	-1.35
EV/EBIT Low	-8.5	0.39	-2.25	-3.29	-1.31	-6.87	-1.51	-0.97	0.11	-0.02
Last Price	- -	- -	90.2	110	217.1	148.8	80.8	42.9	18.4	11.57
High Price	- -	- -	159	124.9	254.9	283	156.7	87.2	61.3	21.5
Enterprise Value Average	-12	-7	167	246	347	954	405	251	149	47
Enterprise Value High	-12	-7	253	293	985	1,338	904	496	339	142
Enterprise Value Low	-12	-7	84	183	93	677	195	87	-27	2

Shares Outstanding	2	2	2	2	5	5	6	6	8	9
Diluted Weighted Avg Shares	1	1	1	2	3	5	5	6	8	8
Basic Weighted Avg Shares	1	1	1	2	3	5	5	6	8	8
Revenue per Share	85.36	73.94	66.71	18.61	13.12	13.42	13.36	25.55	8.02	12.06
EBITDA per Share	10.04	-20.41	-56.75	-22.08	-20.5	-20.31	-24.29	-13.71	-29.89	-11.49
Operating Income per Share	1.95	-27.54	-64.64	-24.16	-21.81	-21.36	-25.41	-14.84	-30.82	-12.35
Basic EPS, GAAP	- -	-28.14	-61.33	-24.28	-9.86	-22.88	-23.49	-17.75	-29.4	-22.49
Basic EPS from Cont Ops	2.43	-28.14	-61.33	-24.28	-9.86	-22.88	-23.49	-17.75	-29.4	-22.49
Diluted EPS, GAAP	- -	-28.14	-61.33	-24.28	-9.86	-22.88	-23.49	-17.75	-29.4	-22.49
Diluted EPS from Cont Ops	2.43	-28.14	-61.33	-24.28	-9.86	-22.88	-23.49	-17.75	-29.4	-22.49
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-18.8	-52.98	22.02	-28.32	-20.82	-17.71	0.7	-18.55	-24.76	-20.86
Free Cash Flow per Basic Share	-25.08	-57.72	19.32	-29.84	-23	-21.03	-0.85	-19.27	-25.16	-21.06
Cash & Equivalents per Share	21.45	9.65	89.5	51.03	80.46	42.73	58.15	61.57	38.4	16.48
Book Value per Share	-41.03	-47.76	57.57	42.33	72.58	54.52	37.75	24.53	5.4	-15.43
Tangible Book Value per Share	-41.03	-47.76	57.57	42.33	72.58	54.52	37.75	24.53	5.4	-15.43

Sutro Biopharma, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)